SH3GLB1 and breast cancer: Moreover, our study of molecular biomarkers, including the Bif-1 gene, could pave the way for biomarkers with therapeutic value shortly; second, it could lead to the production of effective drugs for the treatment of breast cancer patients and especially those patients with Triple Negative Breast Cancer.